Description
ARL2BP Antibody | 15-902 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human
Homology: N/A
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human ARL2BP (NP_036238.1) .
Research Area: Cell Cycle, Signal Transduction
Tested Application: WB
Application: WB: 1:500 - 1:2000
Specificiy: N/A
Positive Control 1: U-251MG
Positive Control 2: MCF7
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: Observed: 19kDa
Validation: N/A
Isoform: N/A
Purification: Affinity purification
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Concentration: N/A
Storage Condition: Store at -20˚C. Avoid freeze / thaw cycles.
Alternate Name: BART, BART1, RP66, ADP-ribosylation factor-like protein 2-binding protein, ADP-ribosylation factor like 2 binding protein, ARF-like 2-binding protein, ARL2-binding protein, Arf-like 2 binding protein BART1, binder of ARF2 protein 1, binder of Arl Two, binder of Arl2, retinitis pigmentosa 66 (autosomal recessive)
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: ADP-ribosylation factor (ARF) -like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. The protein encoded by this gene binds to ARL2.GTP with high affinity but does not interact with ARL2.GDP, activated ARF, or RHO proteins. The lack of detectable membrane association of this protein or ARL2 upon activation of ARL2 is suggestive of actions distinct from those of the ARFs. This protein is considered to be the first ARL2-specific effector identified, due to its interaction with ARL2.GTP but lack of ARL2 GTPase-activating protein activity.